Word: columnist
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...There are so many different messages about nutrition out there these days," says TIME medical columnist Christine Gorman, "that anything that tries to unify recommendations is welcome." To be useful, the Unified Dietary Guidelines go beyond percentages of calories and milligrams to give more concrete advice. Among the suggestions: Choose most of what you eat from plant sources and eat high-fat foods sparingly, especially those from animal sources. The guidelines also give suggested servings. But pay attention to what one serving means, says Gorman. It doesn?t mean a glop of food on a plate. "For fruit and vegetables...
...This is the latest in a string of discoveries that indicate you can create chemicals that can act like estrogen in some parts of the body and as anti-estrogens in other parts of the body," says TIME medical columnist Christine Gorman. In the latest study, for example, the researchers found that raloxifene fits into the body?s estrogen receptors in such a way as to both increase bone density and block breast cancer. There are apparent side effects to raloxifene, however, such as an increased risk of blood clots. And there are also side effects to the other well...
Joel Stein is a columnist and staff writer for TIME magazine...
...have to go to Jerusalem to find people who think they are Jesus or Moses," says TIME medical columnist Christine Gorman. The problem in the Holy Land, however, is that the beauty, the history and the associations of the region can be awesome. "I have never heard of anyone going to the Holy Land," says TIME senior religion reporter Emily Mitchell, "who was not overwhelmed by the emotions it engendered. That can put a severe strain on some mentally fragile people." While cynics may be prone to smirk over the Jerusalem Syndrome, it?s important to remember one thing, says...
...This is something that does happen from time to time,? says TIME medical columnist Christine Gorman. ?Once in the marketplace, a drug is used by millions of people, but during clinical trials, it is tested on only a few thousand people. So occasionally a small risk will get missed in the trials.? Beyond highlighting the fact that safety watchdogs need to continually update the risk-benefit analysis of the drugs they approve, the Trovan incident also underscores a more ominous development. ?We are running into more and more germs that are proving resistant,? says Gorman, ?and as a result...